Combined therapy of mesenchymal stem cells with a GLP-1 receptor agonist, liraglutide, on an inflammatory-mediated diabetic non-human primate model-Reference-Cited by-同舟云学术

Combined therapy of mesenchymal stem cells with a GLP-1 receptor agonist, liraglutide, on an inflammatory-mediated diabetic non-human primate model

Published:2021-07 Issue: Volume:276 Page:119374
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Navabi Roghayeh,Negahdari Babak,Hajizadeh-Saffar Ensiyeh,Hajinasrollah Mostafa,Jenab Yaser,Rabbani Shahram,Pakzad Mohamad,Hassani Seyedeh-Nafiseh,Hezavehei Maryam,Jafari-Atrabi Mohammad,Tahamtani Yaser,Baharvand Hossein

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference62 articles.

1. Type 1 diabetes mellitus;Katsarou;Nat Rev Dis Primers,2017

2. Epidemiology of diabetes;Forouhi;Medicine (Abingdon),2014

3. Pathak V, et al. Therapies for type 1 diabetes: current scenario and future perspectives. Clin Med Insights Endocrinol Diabetes, 2019, 12: 1179551419844521.

4. Type 1 diabetes through the life span: a position statement of the American Diabetes Association;Chiang;Diabetes Care,2014

5. (re)generating human beta cells: status, pitfalls, and perspectives;Baeyens;Physiol. Rev.,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking longevity with GLP-1: A key to turn back the clock?;Maturitas;2024-08

2. Cell Therapies and Gene Therapy for Diabetes: Current Progress;Current Diabetes Reviews;2024-05-13

3. Treatment of type 2 diabetes mellitus with stem cells and antidiabetic drugs: a dualistic and future-focused approach;Human Cell;2023-12-01

4. Immunomodulatory potential of human clonal mesenchymal stem cells and their extracellular vesicle subpopulations in an inflammatory-mediated diabetic Rhesus monkey model;Life Sciences;2023-09

5. GLP-1R agonist liraglutide attenuates pain hypersensitivity by stimulating IL-10 release in a nitroglycerin-induced chronic migraine mouse model;Neuroscience Letters;2023-08